Towards a next-generation sequencing diagnostic service for tumour genotyping: A comparison of panels and platforms

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Burghel, George J ^a,b   Hurst, Carolyn D ^b   Watson, Christopher M ^a,c   Chambers, Phillip A ^b   Dickinson, Helen ^a   Roberts, Paul ^a   Knowles, Margaret A ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; FORMALDEHYDE; GENOMIC DNA; K RAS PROTEIN; PARAFFIN; PROTEIN P53; DNA;

ALLELE; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CONTROLLED STUDY; DNA EXTRACTION; EXON; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; HUMAN CELL; MOLECULAR DIAGNOSIS; MOLECULAR DIAGNOSTICS; MUTANT; NEXT GENERATION SEQUENCING; ONCOGENE N RAS; PYROSEQUENCING; SOLID TUMOR; TUMOR GENE; CHEMISTRY; DNA SEQUENCE; GENETICS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; MUTATION; NEOPLASMS; PREVENTIVE HEALTH SERVICE; PROCEDURES;

DIAGNOSTIC SERVICES; DNA, NEOPLASM; FORMALDEHYDE; GENES, NEOPLASM; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MUTATION; NEOPLASMS; PARAFFIN EMBEDDING; SEQUENCE ANALYSIS, DNA;

EID: 84940882447     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/478017     Document Type: Article

References (19)

1. A. De La Chapelle, "Genetic predisposition to colorectal cancer," Nature Reviews Cancer, vol. 4, no. 10, pp. 769-780, 2004.
2. M. R. Stratton, P. J. Campbell, and P. A. Futreal, "The cancer genome," Nature, vol. 458, no. 7239, pp. 719-724, 2009.
3. B. Vogelstein and K. W. Kinzler, "Cancer genes and the pathways they control," Nature Medicine, vol. 10, no. 8, pp. 789-799, 2004.
4. A. Balmain, J. Gray, and B. Ponder, "The genetics and genomics of cancer," Nature Genetics, vol. 33, supplement, pp. 238-244, 2003.
5. L. D. Wood, D. W. Parsons, S. Jones et al., "The genomic landscapes of human breast and colorectal cancers," Science, vol. 318, no. 5853, pp. 1108-1113, 2007.
6. C. Greenman, P. Stephens, R. Smith et al., "Patterns of somatic mutation in human cancer genomes," Nature, vol. 446, pp. 153-158, 2007.
7. J. E. Dancey, P. L. Bedard, N. Onetto, and T. J. Hudson, "The genetic basis for cancer treatment decisions," Cell, vol. 148, no. 3, pp. 409-420, 2012.
8. B. Tran, A. M. K. Brown, P. L. Bedard et al., "Feasibility of real time next generation sequencing of cancer genes linked to drug response: results from a clinical trial," International Journal of Cancer, vol. 132, no. 7, pp. 1547-1555, 2013.
9. C. J. Allegra, J. M. Jessup, M. R. Somerfield et al., "American society of clinical oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy," Journal of Clinical Oncology, vol. 27, no. 12, pp. 2091-2096, 2009.
10. C. S. Karapetis, S. Khambata-Ford, D. J. Jonker et al., "K-ras mutations and benefit from cetuximab in advanced colorectal cancer," The New England Journal of Medicine, vol. 359, no. 17, pp. 1757-1765, 2008.
11. G. M. Frampton, A. Fichtenholtz, G. A. Otto et al., "Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing," Nature Biotechnology, vol. 31, no. 11, pp. 1023-1031, 2013.
12. C. Meldrum, M. A. Doyle, and R. W. Tothill, "Next-generation sequencing for cancer diagnostics: a practical perspective," Clinical Biochemist Reviews, vol. 32, no. 4, pp. 177-195, 2011.
13. P. A. Chambers, L. F. Stead, J. E. Morgan et al., "Mutation detection by clonal sequencing of pcr amplicons and grouped read typing is applicable to clinical diagnostics," Human Mutation, vol. 34, no. 1, pp. 248-254, 2013.
14. L. Mamanova, A. J. Coffey, C. E. Scott et al., "Target-enrichment strategies for next-generation sequencing,"NatureMethods, vol. 7, no. 2, pp. 111-118, 2010.
15. C. C. Pritchard, S. J. Salipante, K. Koehler et al., "Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens," Journal of Molecular Diagnostics, vol. 16, no. 1, pp. 56-67, 2014.
16. R. Kanagal-Shamanna, B. P. Portier, R. R. Singh et al., "Nextgeneration sequencing-based multi-gene mutation profiling of solid tumors using fine needle aspiration samples: promises and challenges for routine clinical diagnostics," Modern Pathology, vol. 27, no. 2, pp. 314-327, 2014.
17. J. E. Morgan, I. M. Carr, E. Sheridan et al., "Genetic diagnosis of familial breast cancer using clonal sequencing," Human Mutation, vol. 31, no. 4, pp. 484-491, 2010.
18. C. M. Watson, L. A. Crinnion, J. E. Morgan et al., "Robust diagnostic genetic testing using solution capture enrichment and a novel variant-filtering interface," Human Mutation, vol. 35, no. 4, pp. 434-441, 2014.
19. C. F. Taylor, F. M. Platt, C. D. Hurst, H. H. Thygesen, and M. A. Knowles, "Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes," Human Molecular Genetics, vol. 23, no. 8, pp. 1964-1974, 2014.